Irritable Bowel Syndrome Trial, Recruiting (NCT07261826)

Irritable Bowel Syndrome Trial, Recruiting NCT07261826 Sponsor: Chen QiYi Condition: Irritable Bowel Syndrome

Printed from Voxsanity (voxsanity.com.au) — NCT07261826 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Irritable Bowel Syndrome

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with one of the specific diseases this trial is studying.
You are 3 years old or older.
You have already received at least one Fecal Microbiota Transplantation (FMT) treatment, which is a procedure where stool from a healthy donor is used to help restore gut bacteria.
Your medical records from before and after treatment are complete and available for review.
You are willing and able to sign a consent form, or you agree to allow your existing medical data to be used in the study.

Who may not be able to join:

Your medical records have too much missing information, making it impossible to properly assess how well the treatment worked.
You have serious health complications that could affect your safety in the study or make it difficult to interpret the results accurately (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 86+15896453859

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07261826

Sponsor: Chen QiYi

Phase: Not Applicable

Status: Recruiting

Condition: Irritable Bowel Syndrome

Trial contact: 86+15896453859

More information: https://clinicaltrials.gov/study/NCT07261826

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with one of the specific diseases this trial is studying.
You are 3 years old or older.
You have already received at least one Fecal Microbiota Transplantation (FMT) treatment, which is a procedure where stool from a healthy donor is used to help restore gut bacteria.
Your medical records from before and after treatment are complete and available for review.
You are willing and able to sign a consent form, or you agree to allow your existing medical data to be used in the study.

Who may not be able to join:

Your medical records have too much missing information, making it impossible to properly assess how well the treatment worked.
You have serious health complications that could affect your safety in the study or make it difficult to interpret the results accurately (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Chen QiYi

Registry

ClinicalTrials.gov

Start date

1 September 2025

Est. completion

30 June 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

8-Week Clinical Cure of Recurrent CDI; Treatment Response in Chronic Constipation at 8 Weeks; Corticosteroid-Free Clinical Remission in IBD at 8 Weeks; Symptom Relief in IBS at 3 Months; Treatment Response in Autism at 12 Weeks; Symptom Improvement in Incomplete Bowel Obstruction; Symptom Resolution in Drug-Induced Enteritis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov